INGENOX
Live / Registered — Registered (as of 09 Jul 2024)
What this means for you
Registered since 09 Jul 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98015547
- Registration number
- 7437794
- Mark type
- Stylized text
- Filed
- 26 May 2023
- Published for opposition
- 23 Apr 2024
- Registered
- 09 Jul 2024
- Attorney of record
- Patrice P. Jean
Goods and services
- Class 005 — Pharmaceuticals: Epigenetic drugs for the treatment, diagnosis, detection and/or prevention of cancer; epigenetic drugs targeting arginine methylation in cancer; inhibitors of arginine methylation for the treatment of cancer; inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of cancer; cancer treatment vaccines; therapeutic vaccines for treating cancer; cancer therapy subsection vaccines; compounds for the treatment, diagnosis, detection and/or prevention of cancer; pharmaceutical products, preparations and substances for the treatment, diagnosis, detection and/or prevention of cancer; biological preparations and substances for the treatment, diagnosis, detection and/or prevention of cancer
- Class 042 — Scientific and technological services: biochemical research and development services; medical research and development services; scientific research and development services; pharmaceutical research and development services; research and development in the field of epigenetic drugs for the treatment, diagnosis, detection and/or prevention of cancer; research and development in the field of epigenetic drugs targeting arginine methylation in cancer; research and development in the field of inhibitors of arginine methylation for the treatment of cancer; research and development in the field of inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of cancer; research and development in the field of cancer treatment vaccines, therapeutic vaccines for treating cancer and/or cancer therapy subsection vaccines; research and development in the field of compounds for the treatment, diagnosis, detection and/or prevention of cancer; research and development in the field of pharmaceutical products, preparations and substances for the treatment, diagnosis, detection and/or prevention of cancer; research and development in the field of biological preparations and substances for the treatment, diagnosis, detection and/or prevention of cancer; consultancy, advisory and/or information services relating to or connected with the aforementioned services
Owner
- INGENOX THERAPEUTICS LIMITED, Oxford, GB
- INGENOX THERAPEUTICS LIMITED, Oxford, GB
- INGENOX THERAPEUTICS LIMITED, Oxford, GB
Prosecution history
- 09 Jul 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 09 Jul 2024 — REGISTERED-PRINCIPAL REGISTER
- 23 Apr 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 23 Apr 2024 — PUBLISHED FOR OPPOSITION
- 03 Apr 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Mar 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Mar 2024 — EXAMINER'S AMENDMENT ENTERED
- 13 Mar 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 13 Mar 2024 — EXAMINERS AMENDMENT E-MAILED
- 13 Mar 2024 — EXAMINERS AMENDMENT -WRITTEN
- 11 Mar 2024 — PREVIOUS ALLOWANCE COUNT WITHDRAWN
- 05 Mar 2024 — WITHDRAWN FROM PUB - OG REVIEW QUERY
- 20 Feb 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 20 Feb 2024 — ASSIGNED TO EXAMINER
- 27 Jun 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED